Page last updated: 2024-08-24

rhodamine 123 and sorafenib

rhodamine 123 has been researched along with sorafenib in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cao, MR; Li, AM; Lü, CW; Luo, RC; Su, N; Wei, L; Yan, X; Zheng, DY1

Other Studies

1 other study(ies) available for rhodamine 123 and sorafenib

ArticleYear
[Reversion of drug-resistant hepatocellular carcinoma cell line BEL-7402/FU by sorafenib].
    Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology, 2009, Volume: 25, Issue:4

    Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzenesulfonates; Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Membrane; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Exocytosis; Flow Cytometry; Humans; Immunohistochemistry; Liver Neoplasms; Niacinamide; Phenylurea Compounds; Pyridines; Reverse Transcriptase Polymerase Chain Reaction; Rhodamine 123; Sorafenib

2009